Microboosting of Atazanavir 300 mg With 50 mg Versus 100 mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study
Phase of Trial: Phase I
Latest Information Update: 24 Sep 2015
At a glance
- Drugs Atazanavir (Primary) ; Ritonavir
- Indications HIV infections
- Focus Pharmacokinetics
- 21 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 15 Oct 2014 Status changed from recruiting to active, no longer recruiting, as per ClinicalTrials.gov record.
- 20 Jan 2014 New trial record